Abstract | OBJECTIVES: To investigate the seroconversion rate and duration of persistence of protective antibody titres after varicella immunisation in children with renal failure. DESIGN: RESULTS: All children initially seroconverted after immunisation. At a mean follow up of 20.3 months, 23 of 28 had protective antibody titres, 4 children having died of unrelated causes. Two children required a third booster dose. 11 children underwent renal transplantation; 10 had protective titres at the time of transplantation and, at a mean of 23.4 months after immunisation, 6 currently have protective titres. Minor side effects occurred after 11 vaccine doses in 9 children. No child developed varicella, despite 10 clear episodes of exposure to the wild-type virus. CONCLUSIONS:
|
Authors | N J Webb, M M Fitzpatrick, D A Hughes, T J Brocklebank, B A Judd, M A Lewis, R J Postlethwaite, P A Smith, G Corbitt |
Journal | Archives of disease in childhood
(Arch Dis Child)
Vol. 82
Issue 2
Pg. 141-3
(Feb 2000)
ISSN: 1468-2044 [Electronic] England |
PMID | 10648369
(Publication Type: Clinical Trial, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antibodies, Viral
- Chickenpox Vaccine
|
Topics |
- Antibodies, Viral
(biosynthesis, blood)
- Chickenpox
(prevention & control)
- Chickenpox Vaccine
(immunology)
- Child
- Child, Preschool
- Female
- Follow-Up Studies
- Herpesvirus 3, Human
(immunology)
- Humans
- Immunization
- Kidney Failure, Chronic
(immunology, surgery)
- Kidney Transplantation
- Male
- Prospective Studies
|